Trial for penile squamous cancer with swollen groin or pelvis nodes
Treatments studied
Part of Cancer, Kidney & urinary clinical trials.
This Phase 3 study tests treatment options for penile squamous cell cancer that has spread to nearby groin and/or pelvic lymph nodes (but not to distant organs). If you have the right stage and haven’t had certain prior treatments, this trial may offer a structured treatment plan and close monitoring.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You can sign an informed consent form and agree to join the study
- Your doctor has found measurable cancer on scans or exams
- Your cancer type is squamous cell carcinoma of the penis confirmed by biopsy
- Your cancer has lymph node involvement (groin and/or pelvis) but no distant spread
- Your general health/activity level is ECOG 0, 1, or 2 (able to do some daily activities)
- You have not had chemotherapy or chemoradiotherapy before
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
This trial tests a new approach to groin lymph node surgery in men with penile cancer. It aims to reduce side effects while still being effective.
This trial tests a combination of two chemotherapy drugs (carboplatin and paclitaxel) plus the immunotherapy drug pembrolizumab (Keytruda) for penile cancer that has spread to nearby lymph nodes. The goal is to see if this combination can shrink or control the cancer before or after surgery.
This trial tests a combination of chemotherapy drugs (paclitaxel, ifosfamide, cisplatin) and an immunotherapy drug (triplizumab) given before surgery for locally advanced penile cancer. The goal is to shrink the tumor and improve outcomes.
This Phase 3 trial tests whether removing specific lymph nodes in the lower pelvis and around the aorta, along with standard curative treatment, improves outcomes for people with locally advanced cervical cancer. It is mainly aimed at patients whose scans show pelvic lymph nodes involved but not clearly cancer in the para-aortic nodes.
This trial tests a new combination treatment for advanced penile cancer that hasn't been treated before. It combines a targeted drug (becotatug vedotin) designed to attack cancer cells with an immunotherapy drug (pucotenlimab) that helps your immune system fight cancer.
Hear when a new Squamous Cell Carcinoma of the Penis, Usual Type trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.